片仔癀拟出资2亿元参投基金 寻找业务新增长点

Core Viewpoint - The company is actively seeking new growth points by investing in the healthcare sector through the establishment of the GaoXin RunXin Fund, which aims to enhance industrial synergy and competitive capabilities while ensuring the development of its main business [1][2]. Investment Details - The GaoXin RunXin Fund has a total scale of 1 billion yuan, with an initial operating period of 7 years, extendable twice for 1 year each [1]. - The fund's primary investment areas include pharmaceuticals, medical devices, healthcare supply chains, health food, synthetic biology, chemical materials, and consumer healthcare, with investments outside healthcare limited to 10% of the fund's total commitment [1]. - The company plans to contribute 200 million yuan, representing 20% of the fund's target fundraising scale, while other partners include CITIC Securities Capital Management and Zhangzhou GaoXin Development Co., Ltd. [1][2]. Strategic Implications - The investment in the GaoXin RunXin Fund is part of the company's strategic development, aimed at leveraging professional investment resources to accelerate the concentration of the pharmaceutical industry and enhance integration capabilities along the supply chain [2]. - The fund is managed by CITIC Securities Capital Management, which has extensive experience in the healthcare investment sector, facilitating deep integration of industry and capital [2]. Financial Considerations - The investment will not be included in the company's consolidated financial statements and will be funded through the company's own or raised funds, ensuring that it does not adversely affect the company's financial and operational status [3]. - The company maintains a stable profitability and low debt ratio, with sufficient bank credit lines, allowing for this investment without impacting normal business operations [3].